SCHEMBL26645434

SCHEMBL26645434

CC1c2cc(-c3ccc(C(F)(F)F)cc3)nn2CCN1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.39
▸ SMO Q99835 2/20 0.38
▸ CHRNB2 P17787 4/20 0.38
▸ CHRNB4 P30926 4/20 0.38
▸ CHRNA3 P32297 4/20 0.38
▸ CHRNA4 P43681 4/20 0.38
▸ ADORA3 P0DMS8 1/20 0.37
▸ MARS1 P56192 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ KCNJ6 P48051 1/20 0.36
▸ KCNJ5 P48544 1/20 0.36
▸ KCNJ3 P48549 1/20 0.36
▸ RAD51 Q06609 1/20 0.36
▸ CHRM4 P08173 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ P2RY14 Q15391 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30623037 0.87 NR1H2 (0.43) GRM5MAPTP2RY14
SCHEMBL30622875 0.86 GRM5 (0.50) GRM5NPC1MAPTRAB9ATACR3
SCHEMBL26645190 0.86 GRM5 (0.50) GRM5NPC1MAPTRAB9ATACR3
SCHEMBL26645493 0.80 GRM5 (0.40) GRM5NPC1RAB9ASMN1; SMN2TACR3
SCHEMBL26645036 0.77 GRM5 (0.39) GRM5SMOCHRNB2CHRNB4CHRNA3
SCHEMBL26645490 0.77 GRM5 (0.39) GRM5SMOCHRNB2CHRNB4CHRNA3
SCHEMBL30622756 0.75 GRM5 (0.45) GRM5TACR3
SCHEMBL26645645 0.74 SMO (0.41) SMOCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL25433103 0.71 GRM5 (0.41) GRM5MAPTSMN1; SMN2
SCHEMBL26645168 0.71 GRM5 (0.41) GRM5MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback